DelveInsight's Factor D Complement Inhibitor Market Insights report includes a comprehensive understanding of current treatment practices, emerging factor D complement inhibitors, market share of ...
BioCryst Pharmaceuticals, Inc. (BCRX) has made great progress in advancing its pipeline. That's because it is currently evaluating the use of oral D Factor inhibitor, known as BCX10013, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results